Optogenetic control shows that kinetic proofreading regulates the activity of the T cell receptor

Abstract

The immune system distinguishes between self and foreign antigens. The kinetic proofreading (KPR) model proposes that T cells discriminate self from foreign ligands by the different ligand binding half-lives to the T cell receptor (TCR). It is challenging to test KPR as the available experimental systems fall short of only altering the binding half-lives and keeping other parameters of the interaction unchanged. We engineered an optogenetic system using the plant photoreceptor phytochrome B (PhyB) as a ligand to selectively control the dynamics of ligand binding to the TCR by light. This opto-ligand-TCR system was combined with the unique property of PhyB to continuously cycle between the binding and non-binding states under red light, with the light intensity determining the cycling rate and thus the binding duration. Mathematical modeling of our experimental datasets showed that indeed the ligand-TCR interaction half-life is the decisive factor for activating downstream TCR signaling, substantiating KPR.

Data availability

All data that were analyzed with the mathematical model are provided in source data files.

Article and author information

Author details

  1. O Sascha Yousefi

    Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5304-729X
  2. Matthias Günther

    Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Maximilian Hörner

    Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Julia Chalupsky

    Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Maximilian Wess

    Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Simon M Brandl

    Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Robert W Smith

    Laboratory of Systems and Synthetic Biology, Wageningen UR, Wageningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  8. Christian Fleck

    Laboratory of Systems and Synthetic Biology, Wageningen UR, Wageningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  9. Tim Kunkel

    Faculty of Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Matias D Zurbriggen

    Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Thomas Höfer

    Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Wilfried Weber

    Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  13. Wolfgang WA Schamel

    Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany
    For correspondence
    wolfgang.schamel@biologie.uni-freiburg.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4496-3100

Funding

Deutsche Forschungsgemeinschaft (GSC-4)

  • O Sascha Yousefi
  • Maximilian Hörner

Deutsche Forschungsgemeinschaft (EXC294)

  • Wolfgang WA Schamel

Deutsche Forschungsgemeinschaft (EXC81)

  • Thomas Höfer

Deutsche Forschungsgemeinschaft (EXC2189)

  • Wolfgang WA Schamel

Deutsche Forschungsgemeinschaft (INST 39/899-1 FUGG)

  • Wolfgang WA Schamel

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Arup K Chakraborty, Massachusetts Institute of Technology, United States

Version history

  1. Received: October 2, 2018
  2. Accepted: March 5, 2019
  3. Accepted Manuscript published: April 5, 2019 (version 1)
  4. Version of Record published: April 29, 2019 (version 2)

Copyright

© 2019, Yousefi et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,321
    views
  • 1,118
    downloads
  • 83
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. O Sascha Yousefi
  2. Matthias Günther
  3. Maximilian Hörner
  4. Julia Chalupsky
  5. Maximilian Wess
  6. Simon M Brandl
  7. Robert W Smith
  8. Christian Fleck
  9. Tim Kunkel
  10. Matias D Zurbriggen
  11. Thomas Höfer
  12. Wilfried Weber
  13. Wolfgang WA Schamel
(2019)
Optogenetic control shows that kinetic proofreading regulates the activity of the T cell receptor
eLife 8:e42475.
https://doi.org/10.7554/eLife.42475

Share this article

https://doi.org/10.7554/eLife.42475

Further reading

    1. Developmental Biology
    2. Immunology and Inflammation
    Tobias Weinberger, Messerer Denise ... Christian Schulz
    Research Article

    Cardiac macrophages are heterogenous in phenotype and functions, which has been associated with differences in their ontogeny. Despite extensive research, our understanding of the precise role of different subsets of macrophages in ischemia/reperfusion (I/R) injury remains incomplete. We here investigated macrophage lineages and ablated tissue macrophages in homeostasis and after I/R injury in a CSF1R-dependent manner. Genomic deletion of a fms-intronic regulatory element (FIRE) in the Csf1r locus resulted in specific absence of resident homeostatic and antigen-presenting macrophages, without affecting the recruitment of monocyte-derived macrophages to the infarcted heart. Specific absence of homeostatic, monocyte-independent macrophages altered the immune cell crosstalk in response to injury and induced proinflammatory neutrophil polarization, resulting in impaired cardiac remodeling without influencing infarct size. In contrast, continuous CSF1R inhibition led to depletion of both resident and recruited macrophage populations. This augmented adverse remodeling after I/R and led to an increased infarct size and deterioration of cardiac function. In summary, resident macrophages orchestrate inflammatory responses improving cardiac remodeling, while recruited macrophages determine infarct size after I/R injury. These findings attribute distinct beneficial effects to different macrophage populations in the context of myocardial infarction.

    1. Immunology and Inflammation
    Tong Feng, Qi Zhang ... Qiao-Feng Wu
    Research Article

    Osteoarthritis (OA) is a degenerative disease with a high prevalence in the elderly population, but our understanding of its mechanisms remains incomplete. Analysis of serum exosomal small RNA sequencing data from clinical patients and gene expression data from OA patient serum and cartilage obtained from the GEO database revealed a common dysregulated miRNA, miR-199b-5p. In vitro cell experiments demonstrated that miR-199b-5p inhibits chondrocyte vitality and promotes extracellular matrix degradation. Conversely, inhibition of miR-199b-5p under inflammatory conditions exhibited protective effects against damage. Local viral injection of miR-199b-5p into mice induced a decrease in pain threshold and OA-like changes. In an OA model, inhibition of miR-199b-5p alleviated the pathological progression of OA. Furthermore, bioinformatics analysis and experimental validation identified Gcnt2 and Fzd6 as potential target genes of MiR-199b-5p. Thus, these results indicated that MiR-199b-5p/Gcnt2 and Fzd6 axis might be a novel therapeutic target for the treatment of OA.